Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTEC: Cholestech any other investors? -- Ignore unavailable to you. Want to Upgrade?

To: John Kratus who wrote (277)	11/3/1997 3:42:00 PM
From: epicure	Read Replies (2) \| Respond to of 710

Monday November 3 12:25 PM EST Company Press Release CBOE to List Options on Cholestech Corporation (CTEC) on Monday, November 10 CHICAGO, Nov. 3 /PRNewswire/ -- The Chicago Board Options Exchange (CB0E) today announced it will begin trading options on Cholestech Corporation (Nasdaq:CTEC) (CBOE: QDT) on Monday, November 10. Cholestech Corporation, located in Hayward, CA, develops, manufactures and markets the Cholestech L.D.X.(R), a proprietary platform technology whose first applications in the preventive care market measure specific analytes to detect various diseases and disorders from a single drop of whole blood within five minutes. QDT options will trade on the January expiration cycle, with introductory expirations in November, December, January and April. Initial strike prices have been set at 12-1/2, 15 and 17-1/2. (Note: strike prices are subject to change based on the price of the underlying security.) BE Partners has been named the Designated Primary Market Maker (DPM) in the options. CBOE, regulated by the Securities and Exchange Commission (SEC), is the pioneer of listed options and the world's largest options marketplace. SOURCE Chicago Board Options Exchange